145040-37-5 Candesartan cilexetil AKSci J10436
 
 
Loading Please Wait...
  J10436    AKSci Reference Standard
Candesartan cilexetil
, >98% (HPLC)
 



IDENTITY
CAS Number:145040-37-5
MDL Number:MFCD00871371
MF:C33H34N6O6
MW:610.66
SPECIFICATIONS & PROPERTIES
Purity:>98% (HPLC)
Spectra:LCMS, HPLC
Physical Form:White to beige powder
Melting Point:163-175°C
Long-Term Storage:Store long-term at 2-8°C

BIOLOGICAL INFO
Solubility:DMSO: =15 mg/mL
Application(s):Specific nonpeptide Ang II receptor (ATR) antagonist
Form:Free Base

REVIEW

 Candesartan selectively blocks the binding of angiotensin II to AT1 in many tissues including vascular smooth muscle and the adrenal glands. This inhibits the AT1-mediated vasoconstrictive and aldosterone-secreting effects of angiotensin II and results in an overall decrease in blood pressure. Candesartan is greater than 10,000 times more selective for AT1 than AT2. Inhibition of aldosterone secretion may increase sodium and water excretion while decreasing potassium excretion.

REFERENCES
[1]Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S: Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003 Sep 6;362(9386):759-66.
[2] Mendis B, Page SR: Candesartan: widening indications for this angiotensin II receptor blocker? Expert Opin Pharmacother. 2009 Aug;10(12):1995-2007.
[3] Baguet JP, Barone-Rochette G, Neuder Y: Candesartan cilexetil in the treatment of chronic heart failure. Vasc Health Risk Manag. 2009;5(1):257-64. Epub 2009 Apr 8.

GHS

Pictograms

Signal Word
Warning

Hazard Statements
H361; H410

Precautionary Statements
P201; P202; P273; P281; P308+P313; P391; P405; P501


Current as of March 26, 2019

AKSci Reference Standards are high-purity, low-impurity compounds suitable for use as standards.


Download SDS

CATEGORIES

 APIs and Bioactives > Angiotensin Receptor Blockers


PubChem